The promoters and CREs of an additional 16 genes were significantly mutated at relapse, including genes with established roles in the biology of MM or other B-cell malignancies such as XBP1, BCL7A, and BCL9 (Supplementary Tables 9 and 10). Here, BCL9 is linked to Miyoshi myopathy.